MTDH and metabolic dysfunction-associated steatohepatitis: This approach also prevented the development of HFD-induced MASH in C57BL/6 mice, suggesting that targeted nanoparticle-delivered AEG-1 siRNA could be both a preventive and therapeutic approach for HCC [48].